Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neurokinin-1 Receptor Antagonists
×
Clear all
Filters
2
NCT06780085
2026-03-23
MK-3475-01H
Merck Sharp & Dohme LLC
Phase 2
Recruiting
96 enrolled